Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ICAM2 |
| Upstream (Parents) |
|---|
| (<<) BBS1 → ICAM2 |
| (<<) CASP6 → ICAM2 |
| (<<) CRLF3 → ICAM2 |
| (<<) GRB2 → ICAM2 |
| (<<) HOXA3 → ICAM2 |
| (<<) ITGB7 → ICAM2 |
| (<<) MAP3K3 → ICAM2 |
| (<<) MAPK13 → ICAM2 |
| (<<) MAPK14 → ICAM2 |
| (<<) PRKCH → ICAM2 |
| (<<) PTAFR → ICAM2 |
| (<<) RHOD → ICAM2 |
| (<<) RHOT2 → ICAM2 |
| (<<) SCG5 → ICAM2 |
| Downstream (Children) |
|---|
| ICAM2 → CASP10 (>>) |
| ICAM2 → CD79A (>>) |
| ICAM2 → CHODL (>>) |
| ICAM2 → DOCK9 (>>) |
| ICAM2 → GLRX (>>) |
| ICAM2 → HLA-DOA (>>) |
| ICAM2 → KLK3 (>>) |
| ICAM2 → MAPK8 (>>) |
| ICAM2 → MMP15 (>>) |
| ICAM2 → NFKB1 (>>) |
| ICAM2 → SH3GL1 (>>) |
| ICAM2 → STAT5A (>>) |
| ICAM2 → TGM2 (>>) |
